EMN
56
-4
FE
44
3
FITB
63
3
PPL
60
3
WDC
55
2
CNX
56
4
BAC
54
3
XEL
57
6
KO
44
2
NVDA
60
3
BA
56
3
DG
6
4
STI
19
12
DTE
67
2
VMC
63
10
IRM
75
2
SEE
46
2
FIS
55
2
MMM
47
2
NEM
44
3
EMN
56
-4
FE
44
3
FITB
63
3
PPL
60
3
WDC
55
2
CNX
56
4
BAC
54
3
XEL
57
6
KO
44
2
NVDA
60
3
BA
56
3
DG
6
4
STI
19
12
DTE
67
2
VMC
63
10
IRM
75
2
SEE
46
2
FIS
55
2
MMM
47
2
NEM
44
3
Financhill
Back

Direxion Daily S&P 500® Bull 2X ETF Vs. Kymera Therapeutics Industry Stock Comparison

Buy
76

SPUU
Direxion Daily S&P 500® Bull 2X ETF

Last Price:
147.68
Seasonality Move:
8.2%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
48.99
Seasonality Move:
65.72%
Buy
76
Direxion Daily S&P 500® Bull 2X ETF (SPUU) is a Buy

Is Direxion Daily S&P 500® Bull 2X ETF a Buy, Sell or Hold?

  • The current Direxion Daily S&P 500® Bull 2X ETF [SPUU] share price is $147.52. The Score for SPUU is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
  • SPUU is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SPUU Stock Price Chart

What is Direxion Daily S&P 500® Bull 2X ETF's stock price today?

  • The Direxion Daily S&P 500® Bull 2X ETF share price today is $147.52
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPUU is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

SPUU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.72 Buy
Relative Strength Index (14 RSI): 63.36 Buy
Chaikin Money Flow: 13385 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (138.94 - 145.28) Buy
Bollinger Bands (100): (127.24 - 140.8) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

SPUU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 145.25 Buy
20-day SMA: 143.32 Buy
50-day SMA: 137.24 Buy
200-day SMA: 124.42 Buy
8-day EMA: 145.66 Buy
20-day EMA: 143.05 Buy
50-day EMA: 138.74 Buy
200-day EMA: 124.67 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

Direxion Daily S&P 500® Bull 2X ETF Earnings Growth & SPUU Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

Direxion Daily S&P 500® Bull 2X ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):